Share This

Hot News @ 三生制藥

 
Related Keyword:三生制藥 , 輝瑞 , 目標價
Related Concept:三生制藥目標價至 , 維持輝瑞 , 三生制藥目標價 , 三生制藥與輝瑞
 
港股醫藥股為什麼漲瘋了? 作者 智通財經 @ 2025-05-28T
智通財經APP獲悉,近期,港股醫藥股迎來爆發式上漲,尤其是創新藥板塊表現尤為亮眼。港股醫藥股的強勢崛起,本質是技術突破、估值修復、資金共振的三重...
Keyword:三生制藥 輝瑞
Concept:三生制藥目標價至 , 維持輝瑞
財經雜志—美國大藥企超100億購入中國一款藥,為什麼? @ 2025-05-24T
跨國藥企對潛在「全球藥王」的爭奪,正變成押注中國藥企的眼光之爭截至2025年5月21日收盤,三生國健已連續三個交易日漲停,三日漲幅72.78%;子公司三生制藥...
Keyword:三生制藥 輝瑞
Concept:三生制藥目標價至 , 維持輝瑞
《大行》里昂升三生制藥(01530.HK)目標價至19.6元 維持「跑贏大市」評級 @ 2025-05-23T16:
里昂發表報告指,三生制藥(01530.HK)日前公布,與輝瑞(PFE.US)就其突破性PD-1/VEGF雙特異性抗體(SSGJ-707)達成中國以外的全球許可轉讓合作。
Keyword:三生制藥 輝瑞 目標價
Concept:三生制藥目標價 , 維持輝瑞
三生制藥:與輝瑞訂許可協議 另或獲入股 @ 2025-05-22T
三生制藥(01530)宣布,集團與輝瑞就PD-1/VEGF雙特異性抗體(SSGJ-707)訂立許可協議。另外,輝瑞將按30日成交量加權平均價認購公司價值1億美元的普通股,...
Keyword:三生制藥 輝瑞 目標價
Concept:三生制藥與輝瑞
 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.